Yahoo Finance Electric Car Wars: Who Will Win The Battle For The $30,000 EV?
The mass market is at stake as automakers vie for a sub-$30,000 compact SUV electric car. Who will take the prize?
The mass market is at stake as automakers vie for a sub-$30,000 compact SUV electric car. Who will take the prize?
TARA-002 demonstrated compelling efficacy and was generally well-tolerated Enrollment in additional cohorts underway with initial results expected in 1H’25 NEW YORK, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced completion of the first cohort of the Phase 2 STARBORN-1 trial evaluating TARA-002, an investigational cell-based immunopotentiator,
iRhythm’s next-generation Zio® monitor demonstrated longer wear duration and analyzable time compared to the prior generation Zio® XT device.Longer wear duration and analyzable time may further improve diagnostic yield, building upon Zio XT service’s superior yield among ambulatory cardiac monitoring services as demonstrated by the prior CAMELOT study findings.1The Zio monitor ECG device has been worn by over 1 million patients since launching in late 2023.2 SAN FRANCISCO, Sept. 09, 2024 (GLOBE
Private equity firm THL Partners on Monday agreed to acquire a majority stake in AMI, in a deal that people familiar with the matter said valued the provider of semiconductor software at roughly $600 million. THL invested in AMI through its flagship Fund IX and its Automation Fund, which invests in technology firms that build automation software and tools.
Bus models in London and Manchester could now spread across the UK
HADDONFIELD, N.J., September 09, 2024--True, global executive talent platform, announced their acquisition of Paradigm Search, known for placing elite engineering and product leaders.
Amid a high valuation for Palantir stock, analysts are focused on artificial intelligence projects moving from trials to deployment.
Monday's Apple iPhone 16 unveiling is key for AI and a reeling stock market. Palantir and Dell will be joining the S&P 500. Elon Musk's xAI has discussed sharing Tesla FSD revenue.
The UFC ‘Noche’ event takes place at the Sphere in Las Vegas
HARTFORD, Conn., September 09, 2024--The Hartford, a leading provider of employee benefits, and Active Minds, a leading mental health nonprofit organization, are expanding their partnership to bring the award-winning Send Silence Packing® exhibit to more than 100 U.S. college and university campuses in 2024 and 2025. Announcing the expanded partnership during National Suicide Prevention Month, Active Minds released new data that shows 76% of Send Silence Packing attendees supported their own wel
WASHINGTON, September 09, 2024--The Honest Kitchen is the official 2024-2025 Partner of American Humane's Second Chance Grants Program.
DOVER, N.H., September 09, 2024--Compliance Scorecard™, a Governance-as-a-Service solution created by MSPs for MSPs, today signed the Cybersecurity and Infrastructure Security Agency (CISA) Secure By Design Pledge underlining its commitment to safeguard the digital landscape for Managed Service Providers (MSPs) and Small and Medium-sized Businesses (SMBs). CISA’s Secure by Design pledge is a voluntary pledge that commits technology manufacturers to seven distinct goals, each of which is designed
SHANGHAI, September 09, 2024--GEESATCOM, China’s private equivalent to "Starlink," has achieved a major milestone in its satellite network project. On September 6, 2024, at 2:30 AM, GEESATCOM successfully launched its third orbital plane from the Taiyuan Satellite Launch Center. This launch deployed 10 satellites, all of which entered their designated orbits and are operating normally.
MIAMI, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the “Company”), a clinical-stage biotechnology company developing PAS-004, a next-generation macrocyclic MEK inhibitor, for the treatment of neurofibromatosis type 1 (NF1) and other cancer indications, today announced the successful completion of long-term chronic toxicity studies in both rats and dogs with its lead candidate PAS-004, currently being investigated in a Phase 1 clinical trial in adv
JERSEY CITY, N.J., September 09, 2024--Imperial Dade, a leading North American distributor of foodservice packaging supplies, industrial products, and janitorial supplies, today announced that Fareed Khan has been appointed as Chief Financial Officer, effective September 9, 2024.
When properly used on base patterns, trendlines can pinpoint entries that let you buy ahead of buy points.
Think Nvidia CEO Jen-Hsun Huang is aggressively dumping shares of his company this year? Just look at what Fidelity is unloading.
"I didn't know any better," the conservative host told her audience.
Wilson came out as gay in 2020 covers same-sex relationships in her new book
PORTLAND, Maine, September 09, 2024--WEX Inc. (NYSE: WEX), the global commerce platform that simplifies the business of running a business, today announced that its board of directors has authorized an amended share repurchase program under which up to an additional $1.0 billion worth of WEX’s common stock may be repurchased, expanding the total authorization to $2.05 billion through December 31, 2025.
– Treatment with verekitug led to rapid PD effects which were sustained for up to 24 weeks, supporting evaluation of dosing intervals of once every 12 or 24 weeks in ongoing Phase 2 clinical trials – – PK/PD modeling predicts substantially higher clinical potency of verekitug compared to reported tezepelumab data – WALTHAM, Mass., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Upstream Bio, Inc., a clinical-stage company developing verekitug, an investigational antagonist of the Thymic Stromal Lymphopoietin